{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T18:24:50Z","timestamp":1789928690754,"version":"4.0.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H10-No-006"],"award-info":[{"award-number":["H10-No-006"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H14-Kokoro-017"],"award-info":[{"award-number":["H14-Kokoro-017"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H17-Kokoro-019"],"award-info":[{"award-number":["H17-Kokoro-019"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H19-Nanji-Ippan-002"],"award-info":[{"award-number":["H19-Nanji-Ippan-002"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H20-Kokoro-022"],"award-info":[{"award-number":["H20-Kokoro-022"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H22-Nanji-Ippan-002"],"award-info":[{"award-number":["H22-Nanji-Ippan-002"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["13680918"],"award-info":[{"award-number":["13680918"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["14207106"],"award-info":[{"award-number":["14207106"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["AS232Z00009G"],"award-info":[{"award-number":["AS232Z00009G"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.braindev.2012.12.002","type":"journal-article","created":{"date-parts":[[2013,1,2]],"date-time":"2013-01-02T22:02:38Z","timestamp":1357164158000},"page":"515-523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Chaperone therapy update: Fabry disease, GM1-gangliosidosis and Gaucher disease"],"prefix":"10.1016","volume":"35","author":[{"given":"Yoshiyuki","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2012.12.002_b0005","unstructured":"Online Mendelian Inheritance in Man (OMIM). An Online Catalog of Human Genes and Genetic Disorders. Baltimore: McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University. http:\/\/www.omim.org\/"},{"key":"10.1016\/j.braindev.2012.12.002_b0010","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.ph.28.030166.002251","article-title":"Functions of lysosomes","volume":"28","author":"De Duve","year":"1966","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.braindev.2012.12.002_b0015","first-page":"7","article-title":"Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activities","volume":"3","author":"Suzuki","year":"2009","journal-title":"Perspect Med Chem"},{"key":"10.1016\/j.braindev.2012.12.002_b0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/rej.2006.9.237","article-title":"Emerging strategies for the treatment of hereditary metabolic storage disorders","volume":"9","author":"Brady","year":"2006","journal-title":"Rejuvenation Res"},{"key":"10.1016\/j.braindev.2012.12.002_b0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/oxfordjournals.jbchem.a133462","article-title":"\u03b2-Galactosidase-neuraminidase deficiency: restoration of \u03b2-galactosidase activity by protease inhibitors","volume":"90","author":"Suzuki","year":"1981","journal-title":"J Biochem"},{"key":"10.1016\/j.braindev.2012.12.002_b0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0009-8981(82)90257-1","article-title":"Galactosialidosis (\u03b2-galactosidase-neuraminidase deficiency): a possible role of serine-thiol proteases in the degradation of \u03b2-galactosidase molecules","volume":"125","author":"Sakuraba","year":"1982","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.braindev.2012.12.002_b0035","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0014-4827(83)90175-1","article-title":"Effects of thiol protease inhibitors on intracellular degradation of exogenous \u03b2-galactosidase in cultured human skin fibroblasts","volume":"148","author":"Ko","year":"1983","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.braindev.2012.12.002_b0040","series-title":"The online metabolic and molecular bases of inherited disease","first-page":"1","article-title":"\u03b2-Galactosidase deficiency (\u03b2-galactosidosis): GM1-gangliosidosis and Morquio B disease","author":"Suzuki","year":"2008"},{"key":"10.1016\/j.braindev.2012.12.002_b0045","first-page":"435","article-title":"Human \u03b2-galactosidase gene mutations in GM1-gangliosidosis: a common mutation among Japanese adult\/chronic cases","volume":"49","author":"Yoshida","year":"1991","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.braindev.2012.12.002_b0050","first-page":"1091","article-title":"Human \u03b2-galactosidase gene mutations in morquio B disease","volume":"49","author":"Oshima","year":"1991","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.braindev.2012.12.002_b0055","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/ana.410310316","article-title":"GM1-gangliosidosis in adults: clinical and molecular analysis of 16 Japanese patients","volume":"31","author":"Yoshida","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2012.12.002_b0060","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/BF00223869","article-title":"\u03b1-Galactosidase gene mutations in Fabry disease: heterogeneous expressions of mutant enzyme proteins","volume":"95","author":"Okumiya","year":"1995","journal-title":"Hum Genet"},{"key":"10.1016\/j.braindev.2012.12.002_b0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0925-4439(94)00082-2","article-title":"The functional role of glutamine-280 and threonine-282 in human \u03b1-galactosidase","volume":"1270","author":"Ishii","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.braindev.2012.12.002_b0070","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1006\/bbrc.1995.2416","article-title":"Galactose stabilizes various missense mutants of \u03b1-galactosidase in Fabry disease","volume":"214","author":"Okumiya","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.braindev.2012.12.002_b0075","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1006\/bbrc.1993.2659","article-title":"Characterization of a mutant \u03b1-galactosidase gene product for the late-onset cardiac form of Fabry disease","volume":"197","author":"Ishii","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.braindev.2012.12.002_b0080","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10545-006-0287-y","article-title":"\u03b2-Galactosidase deficiency: an approach to chaperone therapy","volume":"29","author":"Suzuki","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.braindev.2012.12.002_b0085","unstructured":"The Human Gene Mutation Database (HGMD). Cardiff: Cardiff University. http:\/\/www.hgmd.cf.ac.uk."},{"key":"10.1016\/j.braindev.2012.12.002_b0090","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1073\/pnas.83.13.4859","article-title":"Human \u03b1-galactosidase A: nucleotide sequence of a cDNA clone encoding the mature enzyme","volume":"83","author":"Bishop","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.braindev.2012.12.002_b0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00207037","article-title":"Point mutations in the upstream region of the \u03b1-galactosidase A gene exon 6 in an atypical variant of Fabry disease","volume":"89","author":"Ishii","year":"1992","journal-title":"Hum Genet"},{"key":"10.1016\/j.braindev.2012.12.002_b0100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0925-4439(00)00024-7","article-title":"Characterization of two \u03b1-galactosidase mutants (Q279E and R301Q) found in an atypical variant of Fabry disease","volume":"1501","author":"Kase","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.braindev.2012.12.002_b0105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJM200107053450104","article-title":"Improvement in cardiac function in the cardiac variant of Fabry\u2019s disease with galactose-infusion therapy","volume":"345","author":"Frustaci","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.braindev.2012.12.002_b0110","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1432-1033.1997.00296.x","article-title":"Specific \u03b1-galactosidase inhibitors, N-methylcalystegines \u2013 structure\/activity relationships of calystegines from Lycium chinense","volume":"248","author":"Asano","year":"1997","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.braindev.2012.12.002_b0115","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/glycob\/7.8.1085","article-title":"The effects of calystegines isolated from edible fruits and vegetables on mammalian liver glycosidases","volume":"7","author":"Asano","year":"1997","journal-title":"Glycobiology"},{"key":"10.1016\/j.braindev.2012.12.002_b0120","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/4801","article-title":"Accelerated transport and maturation of lysosomal \u03b1-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor","volume":"5","author":"Fan","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.braindev.2012.12.002_b0125","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0387-7604(01)00216-9","article-title":"Galactonojirimycin derivatives restore mutant human \u03b2-galactosidase activities expressed in fibroblasts from enzyme-deficient knockout mouse","volume":"23","author":"Tominaga","year":"2001","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2012.12.002_b0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.braindev.2012.12.002_b0135","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.braindev.2003.09.006","article-title":"Sphingolipidoses in Turkey","volume":"26","author":"Ozkara","year":"2004","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2012.12.002_b0140","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archneur.1971.00480310086008","article-title":"GM1-gangliosidosis. Correlation of clinical and biochemical data","volume":"24","author":"Suzuki","year":"1971","journal-title":"Arch Neurol"},{"key":"10.1016\/j.braindev.2012.12.002_b0145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF00293589","article-title":"GM1-gangliosidosis: accumulation of ganglioside GM1 in cultured skin fibroblasts and correlation with clinical types","volume":"43","author":"Suzuki","year":"1978","journal-title":"Hum Genet"},{"key":"10.1016\/j.braindev.2012.12.002_b0150","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/S0021-9258(19)42801-9","article-title":"Glycosphingolipid \u03b2-galactosidases. I. Standard assay procedures and characterization by electrofocusing and gel filtration of the enzymes in normal human liver","volume":"249","author":"Suzuki","year":"1974","journal-title":"J Biol Chem"},{"key":"10.1016\/j.braindev.2012.12.002_b0155","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0021-9258(19)42802-0","article-title":"Glycosphingolipid \u03b2-galactosidases. II. Electrofocusing characterization of the enzymes in human globoid cell leukodystrophy (Krabbe\u2019s disease)","volume":"249","author":"Suzuki","year":"1974","journal-title":"J Biol Chem"},{"key":"10.1016\/j.braindev.2012.12.002_b0160","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/S0021-9258(19)42803-2","article-title":"Glycosphingolipid \u03b2-galactosidases. III. Canine form of globoid cell leukodystrophy; comparison with the human disease","volume":"249","author":"Suzuki","year":"1974","journal-title":"J Biol Chem"},{"key":"10.1016\/j.braindev.2012.12.002_b0165","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0021-9258(19)42804-4","article-title":"Glycosphingolipid \u03b2-galactosidases. IV. Electrofocusing characterization in GM1-gangliosides","volume":"249","author":"Suzuki","year":"1974","journal-title":"J Biol Chem"},{"key":"10.1016\/j.braindev.2012.12.002_b0170","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00273261","article-title":"\u03b2-Galactosidase deficiency in juvenile and adult patients. Report of six Japanese cases and review of literature","volume":"36","author":"Suzuki","year":"1977","journal-title":"Hum Genet"},{"key":"10.1016\/j.braindev.2012.12.002_b0175","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0006-291X(88)80108-6","article-title":"GM1-gangliosidosis: abnormalities in biosynthesis and early processing of \u03b2-galactosidase in fibroblasts","volume":"152","author":"Nanba","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.braindev.2012.12.002_b0180","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/275754a0","article-title":"Enzyme replacement using liposome carriers in feline GM1-gangliosidosis fibroblasts","volume":"275","author":"Reynolds","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.braindev.2012.12.002_b0185","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1399-0004.1990.tb03581.x","article-title":"Bone marrow transplantation in canine GM1-gangliosidosis","volume":"38","author":"O\u2019Brien","year":"1990","journal-title":"Clin Genet"},{"key":"10.1016\/j.braindev.2012.12.002_b0190","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ymgme.2008.02.005","article-title":"Beneficial effects of substrate reduction therapy in a mouse model of GM1-gangliosidosis","volume":"94","author":"Elliot-Smith","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.braindev.2012.12.002_b0195","doi-asserted-by":"crossref","first-page":"15912","DOI":"10.1073\/pnas.2536657100","article-title":"Chemical chaperone therapy for brain pathology in GM1-gangliosidosis","volume":"100","author":"Matsuda","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.braindev.2012.12.002_b0200","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1023\/A:1018573518127","article-title":"\u03b2-Galactosidase-deficient mouse as an animal model for GM1-gangliosidosis","volume":"14","author":"Matsuda","year":"1997","journal-title":"Glycoconj J"},{"key":"10.1016\/j.braindev.2012.12.002_b0205","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbadis.2004.03.007","article-title":"N-octyl-\u03b2-valienamine up-regulates activity of F213I mutant \u03b2-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease","volume":"1689","author":"Lin","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.braindev.2012.12.002_b0210","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.braindev.2006.02.002","article-title":"Fibroblast screening for chaperone therapy in \u03b2-galactosidosis","volume":"28","author":"Iwasaki","year":"2006","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2012.12.002_b0215","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/ana.21284","article-title":"Chemical chaperone therapy: clinical effect in murine GM1-gangliosidosis","volume":"62","author":"Suzuki","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.braindev.2012.12.002_b0220","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00018-008-7470-2","article-title":"Chemical chaperone therapy for GM1-gangliosidosis","volume":"65","author":"Suzuki","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.braindev.2012.12.002_b0225","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ymgme.2012.02.012","article-title":"Therapeutic chaperone effect of N-octyl 4-epi-\u03b2-valienamine on murine GM1-gangliosidosis","volume":"106","author":"Suzuki","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.braindev.2012.12.002_b0230","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.1039\/c2cc32065g","article-title":"Tuning glycosidase inhibition through aglycone interactions: pharmacological chaperones for Fabry disease and GM1-gangliosidosis","volume":"48","author":"Aguilar-Moncayo","year":"2012","journal-title":"Chem Commun"},{"key":"10.1016\/j.braindev.2012.12.002_b0235","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejpn.2008.03.004","article-title":"The potential action of galactose as a \u201cchemical chaperone\u201d: increase of \u03b2-galactosidase activity in fibroblasts from an adult GM1-gangliosidosis patient","volume":"13","author":"Caciotti","year":"2009","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.braindev.2012.12.002_b0240","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbrc.2007.12.187","article-title":"Enhanced autophagy and mitochondrial aberrations in murine GM1-gangliosidosis","volume":"367","author":"Takamura","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.braindev.2012.12.002_b0245","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1471-4159.2011.07310.x","article-title":"Lysosomal accumulation of Trk protein in brain of GM1-gangliosidosis mouse and its restoration by chemical chaperone","volume":"118","author":"Takamura","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.braindev.2012.12.002_b0250","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/humu.21516","article-title":"Chemical chaperone therapy: chaperone effect on mutant enzyme and cellular pathophysiology in \u03b2-galactosidase deficiency","volume":"32","author":"Higaki","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1016\/j.braindev.2012.12.002_b0255","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4172\/jpb.1000128","article-title":"Molecular basis of chemical chaperone effects of N-octyl-\u03b2-valienamine on human \u03b2-glucosidase in low\/neutral pH conditions","volume":"3","author":"Jo","year":"2010","journal-title":"J Proteomics Bioinform"},{"key":"10.1016\/j.braindev.2012.12.002_b0260","unstructured":"Luan Z, Li L, Higaki K, Nanba E, Suzuki Y, Ohno K. The chaperone activity and toxicity of ambroxol on Gaucher cells and normal mice. Brain Dev, in press."},{"key":"10.1016\/j.braindev.2012.12.002_b0265","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0960-894X(96)00146-1","article-title":"Synthesis of potent \u03b2-d-glucocerebrosidase inhibitors: N-alkyl-\u03b2-valienamines","volume":"6","author":"Ogawa","year":"1996","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.braindev.2012.12.002_b0270","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bbadis.2007.02.003","article-title":"Enzyme enhancement activity of N-octyl-\u03b2-valienamine on \u03b2-glucosidase mutants associated with Gaucher disease","volume":"1772","author":"Lei","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.braindev.2012.12.002_b0275","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1002\/cbic.200900442","article-title":"Chaperone activity of bicyclic nojirimycin analogues for Gaucher mutations in comparison with N-(n-nonyl)deoxynojirimycin","volume":"10","author":"Luan","year":"2009","journal-title":"ChemBioChem"},{"key":"10.1016\/j.braindev.2012.12.002_b0280","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bcmd.2009.10.003","article-title":"The pharmacological chaperone effect of N-octyl-\u03b2-valienamine on human mutant acid \u03b2-glucosidases","volume":"44","author":"Luan","year":"2010","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.braindev.2012.12.002_b0285","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.braindev.2009.12.005","article-title":"The effect of N-octyl-\u03b2-valienamine on \u03b2-glucosidase activity in tissues of normal mice","volume":"32","author":"Luan","year":"2010","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2012.12.002_b0290","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/cbic.201000323","article-title":"A fluorescent sp(2)-Iminosugar with pharmacological chaperone activity for Gaucher disease: synthesis and iIntracellular distribution studies","volume":"11","author":"Luan","year":"2010","journal-title":"ChemBioChem"},{"key":"10.1016\/j.braindev.2012.12.002_b0295","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ymgme.2010.08.012","article-title":"Chemical chaperone therapy: luciferase assay for screening of \u03b2-galactosidase mutations","volume":"101","author":"Li","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.braindev.2012.12.002_b0300","doi-asserted-by":"crossref","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","article-title":"Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease","volume":"284","author":"Maegawa","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.braindev.2012.12.002_b0305","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/MOP.0b013e32834c20d9","article-title":"Enzyme replacement therapy for lysosomal storage diseases","volume":"23","author":"Lachmann","year":"2011","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.braindev.2012.12.002_b0310","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10545-006-0272-5","article-title":"Substrate reduction therapy of glycosphingolipid storage disorders","volume":"29","author":"Aerts","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.braindev.2012.12.002_b0315","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ymgme.2009.12.006","article-title":"Miglustat in adult and juvenile patients with Niemann-Pick disease type C: long-term data from a clinical trial","volume":"99","author":"Wraith","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.braindev.2012.12.002_b0320","doi-asserted-by":"crossref","unstructured":"Masciullo M, Santoro M, Modoni A, Ricci E, Guitton J, Tonali P, et al. Substrate reduction therapy with miglustat in chronic GM2 gangliosidosis type Sandhoff: results of a 3-year follow-up. J Inherit Metab Dis [serial on the Internet] 2010: Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20821051.","DOI":"10.1007\/s10545-010-9186-3"},{"key":"10.1016\/j.braindev.2012.12.002_b0325","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0006-291X(88)80038-X","article-title":"Cloning, sequencing, and expression of cDNA for human \u03b2-galactosidase","volume":"157","author":"Oshima","year":"1988","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760412003063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760412003063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:47:30Z","timestamp":1759952850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760412003063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0387760412003063"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2012.12.002","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chaperone therapy update: Fabry disease, GM1-gangliosidosis and Gaucher disease","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2012.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}